Quantbot Technologies LP bought a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 2nd quarter, Holdings Channel reports. The fund bought 8,552 shares of the company’s stock, valued at approximately $3,334,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. BlackRock Inc. purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at $5,069,974,000. Norges Bank bought a new stake in HCA Healthcare during the fourth quarter valued at about $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new stake in shares of HCA Healthcare during the fourth quarter worth about $374,037,000. Viking Global Investors LP lifted its holdings in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after buying an additional 649,058 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on the stock. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. TD Cowen decreased their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Wells Fargo & Company raised their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Jefferies Financial Group set a $450.00 price target on HCA Healthcare in a research note on Tuesday, July 14th. Finally, Raymond James Financial set a $528.00 price objective on HCA Healthcare in a research note on Tuesday, July 7th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $462.64.
HCA Healthcare Price Performance
NYSE:HCA opened at $429.08 on Monday. The firm has a market capitalization of $92.90 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. The business has a 50 day simple moving average of $397.16 and a 200-day simple moving average of $443.77. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period last year, the company earned $6.84 earnings per share. HCA Healthcare’s revenue was up 8.7% on a year-over-year basis. As a group, analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is 10.45%.
HCA Healthcare Company Profile
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
- Five stocks we like better than HCA Healthcare
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
